Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Memantine add-on for Improving Cognitive Impairments and Negative Symptoms in Patients With Schizophrenia

NCT02001103 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT02001103
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02001103 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Memantine add-on for Improving Cognitive Impairments and Negative Symptoms in Patients With Schizophrenia
Lead sponsor
National Taiwan University Hospital
Phase
Phase 3
Overall status
Unknown status
Start date
January 31, 2014
Completion date
December 31, 2017
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia